References
- Bardin T, Richette P. 2014. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol. 26(2):186–191.
- Bi HY, Xu CL, Fu HZ, Zhou ZQ, Zhong RJ, Dai M, Wang D. 2020. Two new norneolignans from Callicarpa kwangtungensis. Nat Pro Res. 34(2):197–203.
- Chen L, Li M, Wu JL, Li JX, Ma ZC. 2019. Effect of lemon water soluble extract on hyperuricemia in a mouse model. Food Funct. 10(9):6000–6008.
- Ding JH, Yuan MM, Yu Y, Zhou GP. 2015. Ethyl acetate-soluble chemical constituents from Callicarpa kwangtungensis (II). Zhong Yao Cai. 38(11):2314–2317.
- Feng SX, Zhang M, Bo YI, Hong-Xin WU. 2017a. Research progress on chemical constituents in Callicarpa nudiflora and their pharmacological activities. Chin Tradit Herb Drugs. 48(5):1015–1026.
- Feng SX, Yi B, Zhang M, Xu J, Lin B, Xu WT. 2017b. Iridoid glycosides from Callicarpa nudiflora Hook. Nat Prod Res. 31(2):181–189.
- Fu Y, Yang J, Chen S, Sun X, Zhao P, Xie Z. 2019. Screening, and identification of the binding position, of xanthine oxidase inhibitors in the roots of Lindera reflexa Hemsl using ultrafiltration LC-MS combined with enzyme blocking. Biomed Chromatogr. 33(9):e4577.
- Gao JB, Yang SJ, Yan ZR, Zhang XJ, Pu DB, Wang LX, Li XL, Zhang RH, Xiao WL. 2018. Isolation, Characterization, and structure-activity relationship analysis of abietane diterpenoids from Callicarpa bodinieri as spleen tyrosine kinase inhibitors. J Nat Prod. 81(4):998–1006.
- Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, Yang XF. 2012. Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed). 17(2):656–669.
- Lam DT, Le VTT, Quan PM, Minh PTH, Thuy TTT, Anh NTN, Tai BH, Kiem PV. 2021. Two new terpenoids from the leaves of Callicarpa macrophylla. Nat Pro Res. 35(7):1107–1114.
- Li SX. 2015. Observation on curative effect of C. nudiflora tablets combined with allopurinol tablets in the treatment of hyperuricemia. Practical Clinical J Integ Traditional Chin Western Med. 15(6):77.
- Liang G, Nie Y, Chang Y, Zeng S, Liang C, Zheng X, Xiao D, Zhan S, Zheng Q. 2019. Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice. Phytomedicine. 59(152772):152772.
- Lin CZ, Zhu CC, Zhao ZX, Li XH, Xiong TQ, Xia YY, Ning Y. 2012. Two new abietane diterpenoids from the caulis and leaves of Callicarpa kochiana. Fitoterapia. 83(1):1–5.
- Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W. 2015. Prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015:762820.
- Mei WL, Han Z, Cui HB, Zhao YX, Deng YY, Dai HF. 2010. A new cytotoxic iridoid from Callicarpa nudiflora. Nat Pro Res. 24(10):899–904.
- Mortada I. 2017. Hyperuricemia, Type 2 diabetes mellitus, and hypertension: an emerging association. Curr Hypertens Rep. 19(9):17–770.
- Piątczak E, Kuźma Ł, Kozłowska W, Lisiecki P, Szemraj M, Płachno BJ, Gonciarz W, Chmiela M, Matkowski A, Zielińska S. 2020. Phenylethanoid and iridoid glycosides production in Rehmannia elata N.E. Brown ex Prein. in vitro shoot cultures and their biological activity. Ind Crops Prod. 158:113050.
- Wang ZH, Xu HJ, Zhai YY, Yang LP, Li Q, Huang M, Chen XY, Zhang WK, Meng YL, Zhang QL, et al. 2019. Three new labdane-type diterpenoids from Callicarpa macrophylla Vahl. Nat Pro Res. 33(20):2904–2910.
- Wu AZ, Yuan H, Lin CZ, Wang T, Zhu CC. 2018. Research progress and biosynthesis of phenylethanoid glycosides in Callicarpa. Journal of Guangzhou University of Traditional Chinese Medicine. 35(3):570–574.
- Xu J, Sun Y, Wang M, Ren Q, Li S, Wang H, Sun X, Jin DQ, Sun H, Ohizumi Y, et al. 2015. Bioactive diterpenoids from the leaves of Callicarpa macrophylla. J Nat Prod. 78(7):1563–1569.
- Yi B, Zhang M, Hu YM, Chen T, Wang MY, Fegn SX. 2019. Analysis of constituents from different parts of Callicarpa nudiflora by UPLC-Q-TOF-MS/MS. Zhongguo Zhong Yao Za Zhi. 44(21):4661–4669.